Audited Results of Kilitch Drugs(I) Ltd. Company

(Rs in Cr.)	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Operating Income	181.59	131.60	117.78	105.16	70.02
Manufacturing Expenses	2.61	2.36	2.06	2	1.57
Personnel Expenses	10.03	7.91	7.47	6.15	5.22
Selling Expenses	1.87	0.06	0.09	0.02	0.02
Administrative Expenses	42.65	33.22	30.13	23.63	18.12
Expenses Capitalised	0	0	0	0	0
Cost Of Sales	150.75	111.28	100.61	94.16	64.81
Operating Profit	30.84	20.32	17.17	11	5.21
Other Recurring Income	13.72	6.19	4.60	4.56	4.19
Adjusted PBDIT	44.55	26.51	21.77	15.56	9.40
Financial Expenses	2.13	1.91	0.99	0.66	0.75
Depreciation	1.74	1.24	1.34	0.96	1.14
Other Write offs	0	0	0	0	0
Adjusted PBT	40.69	23.35	19.45	13.93	7.51
Tax Charges	9.53	5.78	3.73	3.40	1.35
Adjusted PAT	31.16	17.57	15.72	10.53	6.16
Non Recurring Items	0	0	0	0	0
Other Non Cash adjustments	0	0	0	0	0
Reported Net Profit	31.16	17.57	15.72	10.53	6.16
Equity Dividend	0	0	0	0	0
Preference Dividend	0	0	0	0	0
Retained Earnings	162.69	131.53	113.96	98.24	87.71

Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article